Preclinical evidence supporting this concept includes the finding that YAP ablation in pancreatic cancer models reversed key immunosuppressive features, blocking MDSC recruitment, favoring antitumor macrophage polarization and T cell reactivation97. This evidence concerns the gene YAP1 and familial pancreatic carcinoma.